These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 1979304
1. Tardive dyskinesia: managing a common neuroleptic side effect. Jeste DV, Krull AJ, Kilbourn K. Geriatrics; 1990 Dec; 45(12):49-54. PubMed ID: 1979304 [Abstract] [Full Text] [Related]
2. Prevention and management of tardive dyskinesia. Jeste DV, Wyatt RJ. J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473 [Abstract] [Full Text] [Related]
3. Comparison of severe and mild tardive dyskinesia: implications for etiology. Gardos G, Cole JO, Schniebolk S, Salomon M. J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550 [Abstract] [Full Text] [Related]
4. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications. Glazer WM, Morgenstern H, Doucette JT. J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030 [Abstract] [Full Text] [Related]
5. Preventing neuroleptic-induced tardive dyskinesia in adults and children. Lam RW, Jeste SD, Jeste DV. Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652 [Abstract] [Full Text] [Related]
7. Tardive dyskinesia: a review and current treatment options. Najib J. Am J Ther; 1999 Jan; 6(1):51-60. PubMed ID: 10423647 [Abstract] [Full Text] [Related]
8. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Pourcher E, Cohen H, Cohen D, Baruch P, Bouchard RH. Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825 [Abstract] [Full Text] [Related]
9. Risk factors for tardive dyskinesia according to primary psychiatric diagnosis. Wolf ME, DeWolfe AS, Mosnaim AD. Hillside J Clin Psychiatry; 1987 Sep; 9(1):3-11. PubMed ID: 2888712 [Abstract] [Full Text] [Related]
10. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality. Modestin J, Vogt Wehrli M, Stephan PL, Agarwalla P. Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879 [Abstract] [Full Text] [Related]
15. Factors in the development of severe forms of tardive dyskinesia. Yassa R, Nair NP, Iskander H, Schwartz G. Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745 [Abstract] [Full Text] [Related]
16. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study. Raja M, Azzoni A. Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708 [Abstract] [Full Text] [Related]
17. A summary of current knowledge of tardive dyskinesia. Baldessarini RJ. Encephale; 1988 Sep; 14 Spec No():263-8. PubMed ID: 2905654 [Abstract] [Full Text] [Related]
18. [Tardive dyskinesia. A possible complication of chronic treatment with neuroleptics]. D'Aquila F, Rampello L. Riv Neurol; 1990 Sep; 60(4):140-5. PubMed ID: 1982720 [Abstract] [Full Text] [Related]
19. Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Nasrallah HA. Ann Clin Psychiatry; 2006 Sep; 18(1):57-62. PubMed ID: 16517454 [Abstract] [Full Text] [Related]
20. Tardive dyskinesia in outpatients on depot phenothiazine. Neehall J. West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]